143 related articles for article (PubMed ID: 2971653)
1. Purification of a 31,000-dalton insulin-like growth factor binding protein from human amniotic fluid. Isolation of two forms with different biologic actions.
Busby WH; Klapper DG; Clemmons DR
J Biol Chem; 1988 Oct; 263(28):14203-10. PubMed ID: 2971653
[TBL] [Abstract][Full Text] [Related]
2. An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I.
Elgin RG; Busby WH; Clemmons DR
Proc Natl Acad Sci U S A; 1987 May; 84(10):3254-8. PubMed ID: 2953025
[TBL] [Abstract][Full Text] [Related]
3. Characterization of somatomedin/insulin-like growth factor receptors and correlation with biologic action in cultured neonatal rat astroglial cells.
Han VK; Lauder JM; D'Ercole AJ
J Neurosci; 1987 Feb; 7(2):501-11. PubMed ID: 2950212
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-binding proteins (IGF-BPs) produced by human skin fibroblasts: immunological relationship to other human IGF-BPs.
Martin JL; Baxter RC
Endocrinology; 1988 Oct; 123(4):1907-15. PubMed ID: 2970958
[TBL] [Abstract][Full Text] [Related]
5. Purification and characterization of a fetal somatomedin from the sheep: similarity to insulin-like growth factor II.
Hey AW; Browne CA; Thorburn GD
Endocrinology; 1988 Jan; 122(1):12-21. PubMed ID: 3335201
[TBL] [Abstract][Full Text] [Related]
6. Isolation of a biologically active fragment from the carboxy terminus of the fetal rat binding protein for insulin-like growth factors.
Wang JF; Hampton B; Mehlman T; Burgess WH; Rechler MM
Biochem Biophys Res Commun; 1988 Dec; 157(2):718-26. PubMed ID: 2974285
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of insulin-like growth factor binding proteins between structure and affinity. 2. Forms released by human and rat liver in culture.
Hossenlopp P; Seurin D; Segovia B; Portolan G; Binoux M
Eur J Biochem; 1987 Dec; 170(1-2):133-42. PubMed ID: 2961564
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory diffusible factor 45 bifunctional activity. As a cell growth inhibitor and as an insulin-like growth factor I-binding protein.
Blat C; Delbe J; Villaudy J; Chatelain G; Golde A; Harel L
J Biol Chem; 1989 Jul; 264(21):12449-54. PubMed ID: 2545709
[TBL] [Abstract][Full Text] [Related]
9. The binding characteristics and biological effects in FRTL5 cells of placental protein-12, an insulin-like growth factor-binding protein purified from human amniotic fluid.
Frauman AG; Tsuzaki S; Moses AC
Endocrinology; 1989 May; 124(5):2289-96. PubMed ID: 2707157
[TBL] [Abstract][Full Text] [Related]
10. Characterization and regulations of the receptor for insulin-like growth factor-I in the FRTL-5 rat thyroid follicular cell line.
Tramontano D; Moses AC; Picone R; Ingbar SH
Endocrinology; 1987 Feb; 120(2):785-90. PubMed ID: 2948816
[TBL] [Abstract][Full Text] [Related]
11. Receptors for insulin-like growth factor-I in plasma membranes isolated from bovine mesenteric arteries.
Bornfeldt KE; Arnqvist HJ; Dahlkvist HH; Skottner A; Wikberg JE
Acta Endocrinol (Copenh); 1988 Apr; 117(4):428-34. PubMed ID: 2968745
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of a unique high molecular weight form of insulin-like growth factor II.
Gowan LK; Hampton B; Hill DJ; Schlueter RJ; Perdue JF
Endocrinology; 1987 Aug; 121(2):449-58. PubMed ID: 2439316
[TBL] [Abstract][Full Text] [Related]
13. Developmental expression of receptors for insulin, insulin-like growth factor I (IGF-I), and IGF-II in rat skeletal muscle.
Alexandrides T; Moses AC; Smith RJ
Endocrinology; 1989 Feb; 124(2):1064-76. PubMed ID: 2536310
[TBL] [Abstract][Full Text] [Related]
14. Structural analogs of human insulin-like growth factor I with reduced affinity for serum binding proteins and the type 2 insulin-like growth factor receptor.
Bayne ML; Applebaum J; Chicchi GG; Hayes NS; Green BG; Cascieri MA
J Biol Chem; 1988 May; 263(13):6233-9. PubMed ID: 2966152
[TBL] [Abstract][Full Text] [Related]
15. Purified preparations of the amniotic fluid-derived insulin-like growth factor-binding protein contain multimeric forms that are biologically active.
Busby WH; Hossenlopp P; Binoux M; Clemmons DR
Endocrinology; 1989 Aug; 125(2):773-7. PubMed ID: 2473891
[TBL] [Abstract][Full Text] [Related]
16. Cultured fibroblast monolayers secrete a protein that alters the cellular binding of somatomedin-C/insulinlike growth factor I.
Clemmons DR; Elgin RG; Han VK; Casella SJ; D'Ercole AJ; Van Wyk JJ
J Clin Invest; 1986 May; 77(5):1548-56. PubMed ID: 2422210
[TBL] [Abstract][Full Text] [Related]
17. Purification and biologic properties of fibroblast somatomedin.
Clemmons DR; Shaw DS
J Biol Chem; 1986 Aug; 261(22):10293-8. PubMed ID: 2426261
[TBL] [Abstract][Full Text] [Related]
18. Isolation from human cerebrospinal fluid of a new insulin-like growth factor-binding protein with a selective affinity for IGF-II.
Roghani M; Hossenlopp P; Lepage P; Balland A; Binoux M
FEBS Lett; 1989 Sep; 255(2):253-8. PubMed ID: 2551732
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I receptors in human glial tumors.
Merrill MJ; Edwards NA
J Clin Endocrinol Metab; 1990 Jul; 71(1):199-209. PubMed ID: 2164527
[TBL] [Abstract][Full Text] [Related]
20. Production of the rat type 1 insulin-like growth factor-binding protein by well differentiated H4EIIC3 hepatoma cells: identification, purification, and N-terminal amino acid analysis.
Unterman TG; Oehler DT; Gotway MB; Morris PW
Endocrinology; 1990 Aug; 127(2):789-97. PubMed ID: 2164920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
